Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. American Cancer Society; 2019;69:7–34.
   PubMed Web of Science ®Google Scholar
• Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. Nature Publishing Group; 2012;490:61–70.
   PubMed Web of Science ®Google Scholar
• Christensen BC, Kelsey KT, Zheng S, et al. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. United States; 2010;6:e1001043.
   PubMed Web of Science ®Google Scholar
• McPherson K, Steel CM, Dixon JM. Breast cancer—epidemiology, risk factors, and genetics. BMJ Br Med J. British Medical Journal; 2000;321:624–628.
   PubMed Web of Science ®Google Scholar
• Johnson KC, Koestler DC, Fleischer T, et al. DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer. Clin Epigenetics. BioMed Central; 2015;7:75.
   PubMed Web of Science ®Google Scholar
• Fleischer T, Frigessi A, Johnson KC, et al. Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol. BioMed Central; 2014;15:435.
   PubMed Web of Science ®Google Scholar
• Teschendorff AE, Gao Y, Jones A, et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. 2016;7. DOI:10.1038/ncomms10478
   Web of Science ®Google Scholar
• Skvortsova K, Masle-Farquhar E, Luu P-L, et al. DNA hypermethylation encroachment at CpG Island borders in cancer is predisposed by H3K4 monomethylation patterns. Cancer Cell. Elsevier; 2019;35:297–314.e8.
   PubMed Web of Science ®Google Scholar
• Leung JWC, Wang Y, Fong KW, et al. Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair. Proc Natl Acad Sci U S A. 2012;109(12):4491–4496.
   Web of Science ®Google Scholar
• Narayan G, Arias-Pulido H, Nandula SV, et al. Promoter hypermethylation of FANCF. Cancer Res. 2004;64(9):2994–2997.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li M, Lu S, et al. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting fanconi anemia-BRCA pathway. Cancer Biol Ther. 2006;5(3):256–260.
   Web of Science ®Google Scholar
• Watt HL, Kharmate G, Kumar U. Biology of somatostatin in breast cancer. Mol Cell Endocrinol. 2008;286(1–2):251–261.
   PubMed Web of Science ®Google Scholar
• Verlaat W, Snijders PJF, Novianti PW, et al. Genome-wide DNA methylation profiling reveals methylation markers associated with 3q gain for detection of cervical precancer and cancer. Clin Cancer Res. 2017;23(14):3813–3822.
   PubMed Web of Science ®Google Scholar
• Leiszter K, Sipos F, Galamb O, et al. Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer. PLoS One. 2015;10(2):e0118332.
   Web of Science ®Google Scholar
• Mori Y, Cai K, Cheng Y, et al. A genome-wide search identifies epigenetic silencing of somatostatin, Tachykinin-1, and 5 other genes in colon cancer. Gastroenterology. 2006;131(3):797–808.
   PubMed Web of Science ®Google Scholar
• Jackson K, Soutto M, Peng D, et al. Epigenetic silencing of somatostatin in gastric cancer. Dig Dis Sci. 2011;56(1):125–130.
   PubMed Web of Science ®Google Scholar
• Ricketts CJ, Morris MR, Gentle D, et al. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma. Epigenetics. 2012;7(3):278–290.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shen H, Withers HG, et al. VGLL4 selectively represses YAP-dependent gene induction and tumorigenic phenotypes in breast cancer. Sci Rep. 2017;7:1–14.
   PubMed Web of Science ®Google Scholar
• Jiao S, Wang H, Shi Z, et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014;25(2):166–180.
   Web of Science ®Google Scholar
• Zhang W, Gao Y, Li P, et al. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res. 2014;24(3):331–343.
   Web of Science ®Google Scholar
• Maia J, Caja S, Strano Moraes MC, et al. Exosome-based cell-cell communication in the tumor microenvironment. Front Cell Dev Biol. Frontiers; 2018;6:18.
   PubMed Web of Science ®Google Scholar
• Syn N, Wang L, Sethi G, et al. Exosome-mediated metastasis: from epithelial–mesenchymal transition to escape from immunosurveillance. Trends Pharmacol Sci. Elsevier Current Trends; 2016;37:606–617.
   PubMed Web of Science ®Google Scholar
• Park SY, Seo AN, Jung HY, et al. Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer. El-Maarri O, editor. PLoS One. Public Library of Science; 2014;9:e100429.
   PubMed Web of Science ®Google Scholar
• Johnson KC, Houseman EA, King JE, et al. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age. Breast Cancer Res. BioMed Central; 2017;19:81.
   PubMed Web of Science ®Google Scholar
• Campan M, Weisenberger DJ, Trinh B, et al. Methylight. In: Tost J, editor. DNA Methylation. Methods in Molecular Biology. Humana Press; 2009. p. 325–337.
   Google Scholar
• Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analyzing data from Illumina’s HumanMethylation450 platform. Bioinformatics. 2015;32:btv560.
   Web of Science ®Google Scholar
• Sheffield NC, Bock C. LOLA: enrichment analysis for genomic region sets and regulatory elements in R and bioconductor. Bioinformatics. Oxford University Press; 2016;32:587–589.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Joyce BT, Liu L, et al. Prediction of genome-wide DNA methylation in repetitive elements. Nucleic Acids Res. Oxford University Press; 2017;45:8697–8711.
   PubMed Web of Science ®Google Scholar